Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT00277732
- Lead Sponsor
- University Ghent
- Brief Summary
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 288
Inclusion Criteria
- 45-75 years
- Body Mass Index >= 25
- Diabetes treatment for at least 12 months
- Regular visitors of the participating community pharmacy
Exclusion Criteria
- Patients taking only insulin (no oral antidiabetic drugs)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The difference between the study groups in the change of blood glucose and HbA1c baseline and after 6 months
- Secondary Outcome Measures
Name Time Method Knowledge about diabetes and treatment after 6 months Therapy adherence Body Mass Index after 6 months Periods of severe hypoglycemia GP visits, emergency room visits and hospitalisations Work days lost Frequency of eye and foot examination
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium